# The Effect of Naproxen on the Pharmacokinetic Profile of LC350189 in Healthy Adults

> **NCT04139824** · PHASE1 · COMPLETED · sponsor: **LG Chem** · enrollment: 24 (actual)

## Conditions studied

- Gout
- Hyperuricemia

## Interventions

- **DRUG:** Xanthine Oxidase Inhibitor
- **DRUG:** nonsteroidal anti-inflammatory drug

## Key facts

- **NCT ID:** NCT04139824
- **Lead sponsor:** LG Chem
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-22
- **Primary completion:** 2020-02-25
- **Final completion:** 2020-02-25
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2020-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04139824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04139824, "The Effect of Naproxen on the Pharmacokinetic Profile of LC350189 in Healthy Adults". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04139824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*